22.418 articles found

New treatment for people with Parkinson's.

Check source for author details

FDA Consum · 2004-07-01

PMID: 15346564

Extrapyramidal symptoms related to adjunctive nizatidine therapy in an adolescent receiving quetiapine and paroxetine.

Bhanji NH, Margolese HC.

Pharmacotherapy · 2004-07-01

DOI: 10.1592/phco.24.9.923.36096PMID: 15303455

[Chronic electrical stimulation of the globus pallidus for treatment of Parkinson's disease].

Ogura M, Tanaka S, Nishibayashi H, Itakura T.

No Shinkei Geka · 2004-07-01

PMID: 15462368

Economic outcomes associated with olanzapine versus risperidone in the treatment of uncontrolled schizophrenia.

Zhao Z.

Curr Med Res Opin · 2004-07-01

DOI: 10.1185/030079904125004097PMID: 15265249

New developments in the treatment of neurological diseases.

Schuster L.

Drug News Perspect · 2004-07-01

PMID: 15334192

[Radiofrequency treatment of cardiac arrhythmias at the Cardiology Center in Iaşi ].

Grecu M, Arsenescu-Georgescu C, Georgescu GI.

Rev Med Chir Soc Med Nat Iasi · 2004-07-01

PMID: 15832970

Ropinirole therapy for Parkinson's disease.

Pahwa R, Lyons KE, Hauser RA.

Expert Rev Neurother · 2004-07-01

DOI: 10.1586/14737175.4.4.581PMID: 15853577

Clinical experience with the novel levodopa formulation entacapone + levodopa + carbidopa (Stalevo).

Silver DE.

Expert Rev Neurother · 2004-07-01

DOI: 10.1586/14737175.4.4.589PMID: 15853578

M4 muscarinic receptors regulate the dynamics of cholinergic and dopaminergic neurotransmission: relevance to the pathophysiology and treatment of related CNS pathologies.

Tzavara ET, Bymaster FP, Davis RJ, Wade MR, Perry KW, Wess J, McKinzie DL, Felder C, Nomikos GG.

FASEB J · 2004-07-01

DOI: 10.1096/fj.04-1575fjePMID: 15231726

Selegiline increases heme oxygenase-1 expression and the cytotoxicity produced by dopamine treatment of neuroblastoma SK-N-SH cells.

Rieder CR, Williams AC, Ramsden DB.

Braz J Med Biol Res · 2004-06-22

DOI: 10.1590/s0100-879x2004000700015PMID: 15264013

Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease.

Benner EJ, Mosley RL, Destache CJ, Lewis TB, Jackson-Lewis V, Gorantla S, Nemachek C, Green SR, Przedborski S, Gendelman HE.

Proc Natl Acad Sci U S A · 2004-06-14

DOI: 10.1073/pnas.0400569101PMID: 15197276

IMPROVED TRANSDERMAL THERAPEUTIC SYSTEM FOR THE TREATMENT OF PARKINSON'S DISEASE

LAUTERBACH THOMAS, SCHACHT DIETRICH WILHELM, WOLFF HANS-MICHAEL, MUELLER WALTER.

· 2004-06-11